Latest News
The challenges of developing combination products: Regulatory complexity and the case for a holistic development strategy
Drug–device combination products are becoming a defining feature of modern pharmaceutical portfolios, shaping how therapies differentiate, extend lifecycle value, and reach patients. Products such as prefilled syringes, autoinjectors, inhalers, transdermal systems and drug-eluting devices are now routine in development pipelines, often improving therapeutic performance and patient experience. Yet...